Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$57.56 - $82.54 $287,800 - $412,700
-5,000 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$72.5 - $100.68 $558,322 - $775,336
-7,701 Reduced 60.63%
5,000 $389,000
Q3 2021

Nov 01, 2021

SELL
$90.24 - $124.05 $1.26 Million - $1.73 Million
-13,950 Reduced 52.34%
12,701 $1.21 Million
Q2 2021

Jul 22, 2021

SELL
$93.66 - $139.27 $127,377 - $189,407
-1,360 Reduced 4.86%
26,651 $3.31 Million
Q1 2021

May 03, 2021

BUY
$116.57 - $155.01 $123,680 - $164,465
1,061 Added 3.94%
28,011 $3.69 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $59,766 - $85,272
600 Added 2.28%
26,950 $3.57 Million
Q3 2020

Nov 04, 2020

SELL
$72.92 - $102.01 $577,526 - $807,919
-7,920 Reduced 23.11%
26,350 $2.69 Million
Q2 2020

Aug 10, 2020

SELL
$55.75 - $92.75 $1.61 Million - $2.68 Million
-28,850 Reduced 45.71%
34,270 $2.98 Million
Q1 2020

May 11, 2020

BUY
$37.9 - $104.44 $339,963 - $936,826
8,970 Added 16.57%
63,120 $3.66 Million
Q4 2019

Feb 10, 2020

BUY
$77.66 - $99.74 $854,260 - $1.1 Million
11,000 Added 25.49%
54,150 $5.01 Million
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $1.24 Million - $1.68 Million
13,725 Added 46.64%
43,150 $3.9 Million
Q2 2019

Aug 12, 2019

BUY
$89.51 - $118.04 $205,873 - $271,492
2,300 Added 8.48%
29,425 $3.47 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $904,908 - $1.41 Million
-14,600 Reduced 34.99%
27,125 $2.35 Million
Q4 2018

Feb 12, 2019

BUY
$56.04 - $82.66 $2.34 Million - $3.45 Million
41,725 New
41,725 $2.63 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wisconsin Capital Management LLC Portfolio

Follow Wisconsin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wisconsin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wisconsin Capital Management LLC with notifications on news.